BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33433833)

  • 1. Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer.
    Kumar S; Agnihotri N
    Mol Cell Biochem; 2021 Apr; 476(4):1765-1781. PubMed ID: 33433833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
    Kumar S; Agnihotri N
    Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent.
    Sun LD; Wang F; Dai F; Wang YH; Lin D; Zhou B
    Biochem Pharmacol; 2015 Jun; 95(3):156-69. PubMed ID: 25850000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
    Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
    Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular chemoprevention by morin - A plant flavonoid that targets nuclear factor kappa B in experimental colon cancer.
    Sharma SH; Kumar JS; Chellappan DR; Nagarajan S
    Biomed Pharmacother; 2018 Apr; 100():367-373. PubMed ID: 29453046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway.
    Gu SM; Lee HP; Ham YW; Son DJ; Kim HY; Oh KW; Han SB; Yun J; Hong JT
    Neuromolecular Med; 2018 Sep; 20(3):312-327. PubMed ID: 29802525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperlongumine attenuates experimental autoimmune encephalomyelitis through inhibition of NF-kappaB activity.
    Gu SM; Yun J; Son DJ; Kim HY; Nam KT; Kim HD; Choi MG; Choi JS; Kim YM; Han SB; Hong JT
    Free Radic Biol Med; 2017 Feb; 103():133-145. PubMed ID: 28011150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperlongumine inhibits lung tumor growth via inhibition of nuclear factor kappa B signaling pathway.
    Zheng J; Son DJ; Gu SM; Woo JR; Ham YW; Lee HP; Kim WJ; Jung JK; Hong JT
    Sci Rep; 2016 May; 6():26357. PubMed ID: 27198178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells.
    Ginzburg S; Golovine KV; Makhov PB; Uzzo RG; Kutikov A; Kolenko VM
    Prostate; 2014 Feb; 74(2):177-86. PubMed ID: 24151226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs.
    Awasthee N; Shekher A; Rai V; Verma SS; Mishra S; Dhasmana A; Gupta SC
    Apoptosis; 2022 Apr; 27(3-4):261-282. PubMed ID: 35122181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y; Wu X; Zhou Y; Jiang H; Pan S; Sun B
    Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperlongumine inhibits neuroinflammation via regulating NF-κB signaling pathways in lipopolysaccharide-stimulated BV2 microglia cells.
    Kim N; Do J; Bae JS; Jin HK; Kim JH; Inn KS; Oh MS; Lee JK
    J Pharmacol Sci; 2018 Jun; 137(2):195-201. PubMed ID: 29970291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NF-κB: bridging the gap between inflammation and cancer in colitis-mediated colon carcinogenesis.
    Setia S; Nehru B; Sanyal SN
    Biomed Pharmacother; 2014 Feb; 68(1):119-28. PubMed ID: 24269000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis.
    Jin BR; Chung KS; Hwang S; Hwang SN; Rhee KJ; Lee M; An HJ
    Neoplasia; 2021 Jun; 23(6):561-573. PubMed ID: 34077834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine inhibits atherosclerotic plaque formation and vascular smooth muscle cell proliferation by suppressing PDGF receptor signaling.
    Son DJ; Kim SY; Han SS; Kim CW; Kumar S; Park BS; Lee SE; Yun YP; Jo H; Park YH
    Biochem Biophys Res Commun; 2012 Oct; 427(2):349-54. PubMed ID: 22995306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.
    Han SS; Tompkins VS; Son DJ; Kamberos NL; Stunz LL; Halwani A; Bishop GA; Janz S
    Biochem Biophys Res Commun; 2013 Jul; 436(4):660-5. PubMed ID: 23764397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grape seed extract efficacy against azoxymethane-induced colon tumorigenesis in A/J mice: interlinking miRNA with cytokine signaling and inflammation.
    Derry MM; Raina K; Balaiya V; Jain AK; Shrotriya S; Huber KM; Serkova NJ; Agarwal R; Agarwal C
    Cancer Prev Res (Phila); 2013 Jul; 6(7):625-33. PubMed ID: 23639480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
    J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.